AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DXS International plc

Management Reports Dec 19, 2025

10284_agm-r_2025-12-19_a81e1a2f-bb40-4a20-a7cb-dd41ccd28418.html

Management Reports

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

19 December 2025

DXS INTERNATIONAL PLC (AQSE: DXSP)

Result of DXS AGM 2025

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's Annual General Meeting ("AGM") held yesterday were duly passed.

All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.

Resolution Votes For * % Votes

Against
% Votes Withheld **
Resolution 1 14,681,963 100.00 0 0.00 0
Resolution 2 14,647,713 99.77 34,250 0.23 0
Resolution 3 14,671,963 99.97 5,000 0.03 5,000
Resolution 4 14,671,963 99.97 5,000 0.03 5,000
Resolution 5 14,676,963 99.97 5,000 0.03 0
Resolution 6 14,671,963 99.97 5,000 0.03 5,000

*    Includes discretionary votes

**  A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions

During the AGM, the Company's CEO, David Immelman, provided an update on DXS’s progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman



DXS International plc



www.dxs-systems.com
01252 719800
AQSE Corporate Broker and Corporate Advisor



Hybridan LLP



Claire Louise Noyce
020 3764 2341

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

Attachment

Talk to a Data Expert

Have a question? We'll get back to you promptly.